The tumor suppressor protein p53 has a critical role in safeguarding the integrity of the genome. Its functions are well understood but factors responsible for the transcriptional regulation of the p53 gene are almost entirely unknown. The DNA replication-related element (DRE)/ DNA replication-related element-binding factor (DREF) transcriptional regulatory system is established as a master key to cell proliferation in Drosophila. DREF binds specifically to DRE sequences in the Drosophila p53 (dmp53) gene promoter as shown using anti-DREF antibodies in chromatin immunoprecipitation assays. Furthermore, a rough eye phenotype because of overexpression of DREF in Drosophila eye imaginal disks could be suppressed by half dose reduction of the dmp53 gene. In addition, the level of mRNA of dmp53 was decreased in DREF-knockdown cells and transient expression of the luciferase gene under control of the wild-type dmp53 gene promoter showed strong promoter activity in S2 cells, but this was almost completely abrogated with a DRE-mutated promoter. Requirement of DREs for dmp53 promoter activity was further confirmed by anti-b-galactosidase antibody-staining of various tissues from transgenic flies carrying dmp53 promoter-lacZ fusion genes. These results indicate that DREF is necessary for dmp53 gene promoter activity.
Introduction
p53 is a critical component of the cellular mechanisms that respond to genotoxic stresses such as DNA damage and hypoxia to maintain the genomic integrity, in part by arresting cell-cycle progression or inducing apoptosis (Harris, 1996; Burns and El-Deiry, 1999; Sogame et al., 2003) . Loss of function or mutations of the p53 gene are features of almost all common human cancers (Somasundaram, 2000; Sharpless et al., 2002) . However, the molecular regulation of p53 expression is poorly understood, despite the broad knowledge of its functions.
Drosophila p53 (dmp53) has little sequence similarity with human p53 (Brodsky et al., 2000) but structurally and functionally p53 has proven to be conserved from flies to mammals (Jin et al., 2000; Ollmann et al., 2000) and the conservation of potential regulatory domains in dmp53 protein also suggests that some of the proteins that modulate p53 activity are conserved between mammals and Drosophila (Brodsky et al., 2000) . Moreover, like mammalian p53, dmp53 binds specifically to human p53-binding sites in the genome and it is required to maintain normal histone H3-K14 acetylating levels and radiation-induced apoptosis. However, unlike mammalian p53, dmp53 appears unable to induce a G1 cell-cycle block when overexpressed (Ollmann et al., 2000; Brodsky et al., 2004; Rebollar et al., 2006) .
The homodimeric transcription factor, DNA replication-related element (DRE)-binding factor (DREF) is known to have an important role in regulating DNA replication and cell proliferation-related genes in Drosophila by binding to DRE sites (5 0 -TATCGAT A-3 0 ) of target genes (Hirose et al., 1993; Ohno et al., 1996; Takahashi et al., 1996; Ryu et al., 1997; Sawado et al., 1998; Choi et al., 2000; Matsukage et al., 2008) . Recently, a homolog of DREF has been identified in humans, which may also regulate genes related to cell proliferation (Ohshima et al., 2003; Yamashita et al., 2007) . Serial analysis of gene expression showed that a number of genes selectively expressed in actively dividing cells located anterior to the morphogenetic furrow of the eye imaginal disk carry DREs in their 5 0 -flanking regions (Jasper et al., 2002) . Ectopic expression of the dominant-negative form of DREF using the GAL4-UAS targeted expression system causes inhibition of both endoreplication in larval salivary gland cells and mitotic DNA replication in eye disk cells . Ectopic expression of full-length DREF in eye imaginal disks induces ectopic DNA synthesis and apoptosis in otherwise post-mitotic cells, and inhibits photoreceptor cell differentiation that results in a severe rough eye phenotype (Hirose et al., 2001) . RNA interference (RNAi)-mediated knockdown of DREF in growing tissues has also provided direct evidence that the factor is necessary for cell cycle and cell growth control (Yoshida et al., 2004; Hyun et al., 2005) . However, although 24 suppressor genes and 12 enhancer genes for the DREF-induced rough eye phenotype have been identified on the X and second chromosomes , the mechanisms that direct apoptosis in which DREF may be involved have yet to be clarified.
In this study, we identified three DRE sequences located in the 5 0 -flanking region of the dmp53 gene located on the third chromosome, and analyzed the role of DREF in transcriptional regulation of this gene. Our results indicate that the DRE/DREF pathway is a key regulator of dmp53 gene expression, suggesting a novel link between DREF and dmp53-related functions.
Results

Location of DRE and DRE-like sequences in the 5
0 -flanking region of the dmp53 gene Two consensus DRE sequences and one DRE-like sequence were found within the 1-kb genomic region from the transcription initiation site of the dmp53 gene through a public database search (http://www.ncbi.nlm. nih.gov.CG33336). One DRE-like sequence, 5 0 -AATCG ATA-3 0 , was named as DRE1 located at nucleotide positions À59 to À66 with respect to the transcription initiation site as þ 1 with 7 out of 8 bp matching the DRE sequence. Two DREs, 5 0 -TATCGATA-3 0 , were named as DRE2 (À643 to À650) and DRE3 (À654 to À661), both of which were found to perfectly match the 8-bp DRE sequence (Figure 1a ). In addition, these DRE sequences are highly conserved among the Drosophila species (Figure 1b ). These observations suggest that the dmp53 gene is a likely target of DREF.
Half reduction of the dmp53 gene dose suppresses the DREF-induced rough eye phenotype Overexpression of DREF-induced ectopic DNA synthesis and apoptosis and inhibited photoreceptor cell differentiation in eye imaginal disks, so that adult flies showed a mild rough eye phenotype (Figures 2a and b) , although they are known to be viable and fertile (Hirose et al., 2001) . Therefore, these flies are useful genetic tool for screening mutants for genes whose products affect phenotype induced by DREF overexpression Nakamura et al., 2008; Ida et al., 2009) .
Previous genetic screening of modifiers of the DREFinduced rough eye phenotype identified 24 suppressors and 12 enhancers . However, the mutations screened were located in the X and second chromosomes, so that there is only limited information on third chromosomal genes that could genetically interact with the DREF gene. The dmp53 gene is localized in position 94D10 of the third chromosome. As we identified three DRE or DRE-like sequences located in the 5 0 -flanking region of the dmp53 gene, we performed genetic crossing between the DREF overexpressing strain and dmp53 -ns null mutant flies. As expected half reduction of the dmp53 gene dose suppressed the DREF-induced rough eye phenotype (Figures 2c and d ) and the suppression was more evident in homozygous dmp53 mutant background (Figures 2e and f) , suggesting again that the dmp53 gene is a target of DREF.
DREF binds to the genomic region of dmp53 containing DRE and DRE-like sequences in vivo To examine DREF capacity for binding to the genomic region containing DRE and DRE-like sequences in the dmp53 gene, we performed chromatin immunoprecipitation assays with Drosophila S2 cells using affinity puried anti-DREF polyclonal antibodies. It is well known that the proliferating-cell nuclear antigen promoter contains DREs to which DREF specifically binds (Hirose et al., 1993; Yamaguchi et al., 1996; Seto et al., 2006) , so that it was used as a positive control and the Actin 5C (Act 5C) genomic region that does not carry DRE was used as a negative control for this examination. One primer pair was chemically synthesized to amplify the DRE1 region and another for the region containing DRE2 and three from immunoprecipitates with anti-DREF IgG (Figure 1) . Amplification of the region containing DRE1 was 14-fold and that of DRE2 region and the three regions were 28.5-fold higher than with amplification from immunoprecipitates with control IgG. Amplification of the proliferating-cell nuclear antigen gene promoter region containing DRE and the Act5C genomic region in the immunoprecipitates with anti-DREF antibody was 27.6 and 3.7 fold, respectively ( Figure 3) . Thus, we conclude that DREF binds to the genomic region containing the DRE1 and DRE2, DRE3 of the dmp53 in cultured cells.
Role of DRE and DRE-like sequences in dmp53 promoter activity As DREF binds to DRE-containing genomic region of the dmp53 gene, we analyzed the significance of these DREs in dmp53 promoter activity. We constructed reporter plasmids containing the dmp53 promoter region with or without mutations in the DRE fused to a luciferase reporter (Figure 4 ). Base-substitution mutations in DRE were designed on the basis of a previous report (Yamaguchi et al., 1995) . The plasmids were then transfected into Drosophila S2 cells and luciferase Role of DREF in transcriptional regulation N Trong-Tue et al expression levels were determined. As shown in Figure 4 , mutations in all DREs of dmp53 resulted in extensive reduction by 94% of luciferase expression as compared with the wild-type promoter. The luciferase activity with the plasmid carrying base substitutions in DRE1 was decreased to o15% of that with the wild-type dmp53 promoter and combinational mutations of DRE1 with DRE2 or DRE3 resulted in reduction of the luciferase activity to o6%. However, mutations in DRE2 or DRE3 alone exerted no or only slight change in the luciferase activity in compared with the wild-type promoter ( Figure 4 ). These data indicate that DRE1 has the most important role in dmp53 promoter activity.
Beside the results of luciferase transient expression assay in S2 cells, we analyzed the role of DRE in dmp53 promoter activity in living flies. The wild-type dmp53 promoter and the examples carrying mutations in all three DREs were fused to lacZ (p5 0 -dmp53wt-LacZ and p5 0 -dmp53mutDREall-LacZ) and transgenic flies were established (Table 1 ). The b-galactosidase protein expression of the transgenic larvae was evaluated by immunohistochemistry with anti-b-galactosidase antibodies. Strong b-galactosidase expression was detected in nuclei of salivary glands, wing disks, brain lobes, eye disks and leg disks from third instar larvae carrying the dmp53wt-LacZ (Figures 5a, c, e, g and i). In contrast, no staining was detected in the same tissues from larvae carrying the dmp53mutDREall-LacZ (Figures 5b, d , f, h and j). These results thus further confirmed that DREs are required for dmp53 promoter activity.
It is known that the boundary element-associated factor binds to 5 0 -CGATA-3 0 motif that overlaps to the DRE sequence (Zhao et al., 1995) . The DRE2,3mut disrupts two DRE-binding sequences but still carries the 5 0 -CGATA-3 0 sequence (Figure 4 ). In addition, another putative boundary element-associated factor-binding sequence (5 0 -TATCG-3 0 ) exists at the nucleotide position -341 to -337. Therefore, the DREmutall disrupts all three DRE-binding sequences but still carries at least two boundary element-associated factor-binding sequences. As the DREmutall shows only a marginal promoter activity in both cultured S2 cells and transgenic flies, it is not likely that boundary elementassociated factor has a role in dmp53 promoter activity.
Knockdown of the DREF gene reduces expression of the endogenous dmp53 gene In RNAi-mediated DREF-knockdown cells, endogenous dmp53 gene expression was examined to show that DREF is required for dmp53 gene promoter activity. Reduction of DREF protein in DREF-double-stranded RNA (dsRNA)-treated cells was confirmed by western immunoblot analyses with anti-DREF antibodies (Figure 6a ). Total RNAs from dsRNA-treated S2 cells were isolated and quantitative reverse transcriptase-PCR was carried out to measure the levels of mRNAs.
The DREF mRNA level was reduced by 95% in DREF-dsRNA-treated cells, but was only slightly changed in LacZ-dsRNA-treated cells as compared with no-dsRNA treatment cells (mock) (Figure 6b ). Under these conditions, the level of dmp53 mRNA was decreased more than 50% relative to that with no RNAi treatment (Figure 6b ). For a negative control, b-tubulin mRNA was examined and its level was not affected by DREF-dsRNA treatment (Figure 6b ). From these data, we conclude that the dmp53 gene is upregulated by DREF.
Effects of knockdown of the DREF gene on dmp53 gene promoter activity
To further analyze the requirement of DREF for dmp53 promoter activity, we performed luciferase transient expression assays in DREF-knockdown cells. DREFdsRNA or LacZ-dsRNA were added to S2 cells to knockdown the dmp53. Western immunoblot analyses with anti-DREF antibody revealed that DREF protein was not detectable at 3, 5 and 7 days after DREFdsRNA treatment, while no change was evident in mock and LacZ-dsRNA-treated cells (Figure 6a ). When luciferase reporter plasmids were transfected into S2 cells at 5 days after RNAi treatment, the wild-type dmp53 promoter activity was decreased to 71% compared with no-dsRNA treatment cells (mock) in DREFdsRNA-treated cells, while the dmp53 promoter activity was only slightly changed in the LacZ-dsRNA-treated case (Figure 6c ).
To further confirm dependence of promoter activation by DREF on DREs, we determined luciferase expression with the dmp53 promoter containing mutations in DRE in DREF-knockdown S2 cells. As the role of DRE1 was the most important for dmp53 promoter activity, as described above, we measured luciferase activities in cells transfected with the p5 0 -dmp53mutDRE1-luc. The data indicated no significant change in luciferase activity in DREF-knockdown cells as compared with controls ( Figure 6c ). These results again confirm that the positive role of DREF in dmp53 promoter activity is mainly mediated by DRE1.
Activation of endogenous dmp53 gene expression in eye imaginal disks from flies overexpressing DREF To address whether overexpression of DREF can activate dmp53 gene expression in vivo, we used the fly line GMR-GAL4/ þ ; UAS-DREF/ þ ; þ for immunostaining of the eye imaginal disks in which DREF is overexpressed in the region posterior to the morphogenetic furrow (Hirose et al., 2001) . As reported earlier, overexpression was confirmed by immunostaining with anti-DREF antibodies (Figure 7g ). Immunostaining with anti-dmp53 antibodies further showed ectopic dmp53 signals in the same region posterior to the morphogenetic furrow in the eye disks (Figure 7a ). However, in control samples from the fly line GMR-GAL4/ þ / þ , no staining with the anti-dmp53 antibodies was detected (Figures 7b, c, h and i) . The specificity of anti-dmp53 antibody used in this analysis is confirmed by the western immunoblotting with third instar larval extracts from Canton S and immunostaining of the eye imaginal disks overexpressing dmp53 (Supplementary Figure 1) .
Discussion
In thist study, we have identified three potential DREFbinding sequences (DRE) in the 5 0 -flanking region of the dmp53 gene (Figure 1 ) and showed that DRE1 in particular is required for dmp53 promoter activity in cultured cells and living flies. We also showed DREF binding to the genomic region of the dmp53 gene containing DREs and positive regulation of dmp53 gene expression at the transcriptional level. The observed rescue of the DREF-induced rough eye phenotype by half-reduction of the dmp53 gene dosage is consistent with the idea that dmp53 gene transcription is activated by DREF. The other observation that GMR-GAL4-driven overexpression of DREF activates endogenous dmp53 in eye imaginal disks is also very indicative that the DRE/DREF system is a key regulator of dmp53 gene expression in Drosophila, although further genome-wide analysis of DREF occupancy by ChIP assay in relation to gene expression changes may increase the significance of our findings. Remarkably, search for human DREFbinding sequences in the 5 0 -flanking and 5 0 -untranslated region of the human p53 gene on the genome database revealed two such sequences at nucleotide positions ( þ 1426 to þ 1435) and ( þ 2777 to þ 2786) (Ohshima et al., 2003) . Therefore, potential regulatory sites are likely to be conserved between human and Drosophila p53 genes and human p53 may be similarly regulated by . (a, c, d , g, h) Salivary gland, wing disk, brain lobe, eye imaginal disk and leg disk in the third instar larvae; (b, e, f, i, j) Salivary gland, wing disk, brain lobe, eye imaginal disk and leg disk in the third instar larvae with the DRE1-, DRE2-and DRE3-mutated dmp53 promoter-LacZ fusion genes.
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N Trong-Tue et al human DREF pathway, although further analyses are necessary to address this point. DREF is known to have an important role in regulation of DNA replication, the cell cycle, proliferation and apoptosis (Hirose et al., 1993; Ohno et al., 1996; Takahashi et al., 1996; Ryu et al., 1997; Sawado et al., 1998; Matsukage et al., 2008) . Ectopic expression of human p53 and dmp53 using a GMR-GAL4 driver and upstream element UAS in the fly eye disk initiates apoptosis and induces rough eye phenotype (Yamguchi et al., 1999; Jin et al., 2000) . Therefore, effects of DREF on apoptosis may be mediated by transcriptional activation of dmp53, pointing to similar upstream targets of vertebrate and Drosophila p53. Predominant expression of dmp53 in germ lines as well as during embryogenesis indicates a role for dmp53 as a teratogenesis suppressor (Jin et al., 2000) . As the Dmp53 mRNA level was reduced by more than 50% when DREF was knocked down in this study, DREF functions could contribute to suppression of embryo teratogenesis indirectly.
DREF has been shown to bind to multiple genomic regions containing DRE and DRE-like sequences of various Drosophila genes (Thao et al., 2006; Ida et al., 2007; Tsuchiya et al., 2007; Nakamura et al., 2008; Suyari et al., 2009 ). However, in many cases DREs located within 300-bp upstream region from the transcription initiation site of the genes appear to have the most important role in promoter activity, as proven with genes such as skpA, eIF4a, rfc1, moira, orc2 and ANT (Okudaira et al., 2005; Thao et al., 2006; Ida et al., 2007; Kim et al., 2007; Tsuchiya et al., 2007; Nakamura et al., 2008) . Similarly in this study, dmp53-DRE2 (À643 to À650) and dmp53-DRE3 (À604 to À661) exerted no significant effect on promoter activity, while dmp53-DRE1 (À59 to À66) had a critical role. Therefore, the distance of DRE from the transcription initiation site may be important in promoter activity.
Expression of lacZ in transgenic flies carrying dmp53wt-LacZ was detected in the salivary glands, leg disks, wing disks, eye disks and brain lobes by anti-bgalactosidase antibody (Figure 5 ), while expression was lacking in flies carrying dmp53mutDREall-LacZ in the same tissues. In addition, flies with no functional dmp53 gene are viable, albeit sickly with a shortened life span (Sogame et al., 2003; Bauer et al., 2005) . Therefore, DRE sequences in the dmp53 gene promoter may be Role of DREF in transcriptional regulation N Trong-Tue et al important for its normal function. Further, p53 transgene rescue experiments by using the targeted transgenesis systems would be necessary to further confirm the significance of the DRE sequences for p53 function in vivo.
In conclusion, this study indicates that the DRE/ DREF system is a key regulator of dmp53 gene expression in Drosophila. It would therefore be interesting to further examine the possibility that other tumor suppressor genes are also regulated by the DRE/DREF pathway in Drosophila. By database search, we have found DRE and DRE-like sequences in the upstream region of tumor suppressor genes such as Rbf, APC, Brca2, NF1 and Vhl. The DRE and DRE-like sequences and their positions from the transcription initiation sites are summarized in Table 2 . These findings raise the possibility that many other tumor suppressor genes are also regulated by DREF in Drosophila. 
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Materials and methods
Fly strains
Fly strains were maintained at 25 1C on standard food. We used the Canton S fly as a wild-type strain. The dmp53 null mutant fly line was kindly supplied by Dr M Abrams. This line was generated by homologous recombination and is homozygous viable (Sogame et al., 2003) . The UAS-DREF line was described earlier (Hirose et al., 2001) as well as the transgenic fly line carrying GMR-GAL4 on the X chromosome (Takahashi et al., 1999) . All other stocks used in this study were obtained from the Bloomington, IN, USA stock center.
Establishment of transgenic flies
The P element-mediated germ line transformation was carried out as described earlier (Spradling, 1986) and F1 transformants were selected on the basis of white-eye color rescue (Robertson et al., 1988) . On the basis of the casper-nls-lacZ plasmid provided by Dr Dean Smith (Galindo and Smith, 2001 ), p5 0 -dmp53wt-LacZ and p5 0 -dmp53mutDREall-LacZ were constructed and transgenic fly strains were produced with these plasmids. The established transgenic fly lines and their chromosomal linkages are listed in Table 1 .
Oligonucleotides
All oligonucleotides were chemically synthesized. To amplify the 5 0 -flanking region of the dmp53 gene, the following PCR primers were synthesized and used for construction of the dmp53promoter-luciferase gene fusion plasmids or dmp53pro-moter-nls-lacZ fusion plasmids.
For site-directed mutagenesis of DRE sites, the following oligonucleotides were synthesized.
For chromatin immunoprecipitation assays, the following oligonucleotides were synthesized.
For quantitative real-time PCR, the following oligonucleotides were synthesized.
Plasmid construction
The promoter region of the dmp53 gene (À944 to þ 96 with respect to the transcription initiation site) was amplified by PCR using Drosophila genomic DNA. To construct the plasmid p5 0 -dmp53wt-luc, the primer set Dp53XhoIF2 and Dp53BglIIR2 was used to amplify a 1040-bp fragment and the PCR products were digested with XhoI and BglII and inserted into plasmid pGVB (Toyo Ink, New York, NY, USA). For site-directed mutagenesis, PCR was carried out using a QuickChangeSite-directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA), and plasmid p5 0 -dmp53wt-luc was used as a DNA template to make a series of pGVBs carrying mutations in DRE sites for analysis of dmp53 promoter activity. The introduction of each mutation was confirmed by nucleotide sequencing.
To construct the plasmids p5 0 -dmp53wt-LacZ and p5 0 -dmp53mutDREall-LacZ for transgenic flies, PCR was performed using the plasmid p5 0 -dmp53wt-luc and p5 0 -dmp53mutDREall-luc as templates and primers Dp53F.NotI and Dp53R.BamHI to amplify 1040-bp fragment of the promoter region of the dmp53 gene. PCR products were digested with BamHI and NotI and inserted between the BamHI and NotI sites of the pOBP plasmid (Galindo and Smith, 2001) .
DNA transfection into the cells and luciferase assays
Reporter plasmid (700 ng) and pAct5C-seapansy (1 ng) as an internal control were co-transfected into 2 Â 10 5 Drosophila S2 cells using CellFectin reagent (Invitrogen, San Diego, CA, USA). At 48 h after transfection, cells were harvested and luciferase activities were measured with the Dual-Lucifease Reporter assay system (Promega, Madison, WI, USA).
For dsRNA interference experiments, 2 Â 10 5 S2 cells were plated in 24-well dishes in the presence of 30 mg/well of DREFdsRNA, LacZ-dsRNA and mock for control (dsRNA free
Role of DREF in transcriptional regulation N Trong-Tue et al incubation) in fetal bovine serum-free M3(BF) medium for 1 h. After the incubation, three volumes of M3(BF) medium containing 10% fetal bovine serum were added to each well. Four days after the RNAi treatment, the cells were co-transfected with the luciferase-reporter and internal control plasmids and luciferase activities were measured similarly as described above.
Western immunoblot analysis
Proteins were extracted from S2 cells or third-instar lavae and applied to a sodium dodecyl sulfate-polyacrylamide gel containing 12% acrylamide and transferred to polyvinylidenedifluoride membranes (Bio-Rad, Hercules, CA, USA) in transfer buffer (50 mm borate-NaOH, pH9.0 and 20% ethanol). The blotted membranes were incubated with monoclonal antibodies to DREF 
Quantitative reverse transcriptase-PCR
In all, 10 6 S2 cells were exposed to dsRNA (30 mg/well). After 7 days RNAi treatment, total RNA was isolated using Trizol Reagent (Invitrogen). Oligo dT primers and a Takara high fidelity RNA PCR kit (Takara, Kyoto, Japan) were used for generation of complementary DNA. Then, real-time PCR was performed using a SYBR Green I kit (Takara) and the Applied Biosystems 7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA). Levels of mRNAs in the DREFdsRNA-or LacZ-dsRNA-treated cells and non dsRNA-treated cells (mock) were analyzed by the Ct comparative method (Morrison et al., 1998) . The b-tubulin gene was chosen as a negative control with Rp49 gene as an endogenous reference gene. Experiments were performed in triplicate for each of three RNA batches isolated separately.
Scanning electronmicroscopy
Adult flies were anesthetized, mounted on stages and observed under a VE-7800 (Keyence Inc., Osaka, Japan) scanning electron microscope in the high vacuum mode.
Immunohistochemistry
Third instar larvae were dissected in phosphate-buffered saline (PBS) and tissues were fixed in 4% paraformaldehyde/PBS for 30 min at 25 1C. After washing with PBS/0.3% TritonX-100 (PBS-T), the samples were blocked with PBS-T containing 10% normal goat serum for 20 min at 25 1C and incubated with an anti-b-galactosidase monoclonal antibody (Promega) or an anti-DREF monoclonal antibody mixture at a 1:500 dilution and dmp53 monoclonal antibody (Developmental Studies Hybridoma Bank, Iowa City, IA, USA) at 1:100 dilution at 4 1C for 16 h. After extensive washing with PBS-T, the tissues were incubated with an anti-mouse IgG conjugated with Alexa 594 (Molecular Probes, Eugene, OR, USA) at a 1:400 dilution at 4 1C for 16 h. After extensive washing with PBS-T and PBS, samples were mounted in Fluor Guard Antifade Reagent (Bio-Rad) for microscopic observation under a fluorescence BX-50 microscope (Olympus, Tokyo, Japan) equipped with a cooled CCD camera (ORCA-ER; Hamamatsu Photonics KK, Shizuoka, Japan).
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation assays were performed using a ChiP Assay kit as recommended by the manufacturer (Upstate, Temecula, CA, USA). Approximately, 2 Â 10 7 Drosophila S2 cells were fixed in 1% formaldehyde at 37 1C for 10 min and then quenched in 125 mM glycine for 5 min at 25 1C. After washing twice in PBS containing protease inhibitors (1 mM phenylmethylsulphonyl fluoride,1 mg/ml aprotinin and 1 mg/ml pepstatin A) the cells were lysed in 2 ml of sodium dodecyl sulfate lysis buffer and sonicated to break DNA into fragments shorter than 1 kb then centrifuged at 15 300 Â g for 10 min at 4 1C. The sonicated cell supernatants were diluted 10-fold in Chip Dilution Buffer and pre-cleared with 60 ml of Salmon Sperm DNA/Protein G agarose-50% slurry for 30 min at 4 1C. After brief centrifugation, each supernatant was incubated with 1 mg of the rabbit IgG or anti-DREF polyclonal antibodies for 16 h at 4 1C. Salmon sperm DNA/Protein G agarose-50% slurry was added with incubation for 1 h at 4 1C. After washing, immunoprecipitated DNA was eluted with elution buffer (1% SDS and 0.1 M NaHCO 3 ). Then the protein-DNA crosslinks were reversed by heating at 65 1C for 4 h. After deproteinization with proteinase K, DNA was recovered by phenol-chloroform extraction and ethanol precipitation. The immunoprecipitated DNA fragments were detected by quantitative real-time PCR using SYBR Green I (Takara) and the Applied Biosystems 7500 real-time PCR system (Thao et al., 2006; Ida et al., 2007) . Primer pairs for PCR were as described above.
Conflict of interest
The authors declare no conflict of interest.
